Six people, each responsible for a different stage of the lifecycle.
Most of this team came from academic research centers or sponsor-side clinical operations before joining Fairmont Clinical.
Eight years as a practicing internist before founding Fairmont Clinical in 2013. Still reviews every feasibility assessment personally before a site commitment is made.
Oversees active trials across every partner site and owns the relationship with sponsors and CROs once a study is underway.
Manages IRB submissions and GCP compliance across the network. Previously worked regulatory affairs for a mid-sized CRO before joining Fairmont Clinical.
Builds site-specific recruitment plans and has the strongest opinions on the team about why generic advertising rarely finds the right participants.
Runs the internal quality audit process that catches data discrepancies before a sponsor's monitor does, across every active protocol.
Identifies and evaluates new independent practices for the network, and is usually the first person a prospective site talks to.
Curious what this team has learned running trials at independent sites? Read Protocol Notes, or get in touch directly.